Nov. 18, 2019 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that Michael Klein, Chairman and Chief Executive Officer, will
present a corporate overview at the Canaccord Genuity MedTech & Diagnostics
Forum, taking place Thursday, November 21st in New York City.
Thursday, November 21, 2019
10:00am Eastern Time
Headquartered in Nashua, NH, iCAD is a global medical technology leader
providing innovative cancer detection and therapy solutions. For more
information, visit www.icadmed.com.
Jessica Burns, iCAD
Jeremy Feffer, LifeSci Advisors